Pharmaceuticals in India
Summary
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Indian pharmaceuticals market had total revenues of $32,500.0m in 2019, representing a compound annual growth rate (CAGR) of 2.2% between 2015 and 2019.
- The Indian market is growing, driven by an increase in real GDP, doctors and India’s population covered by insurance. A number of major government initiatives are set to support this growth in the future
- The Indian market supplies around 40% of generic demand in the US and 25% of all medicine in the UK. Around 80% of the world’s antiretroviral drugs used in the treatment of HIV/AIDs are made in India.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the India pharmaceuticals market by value in 2019?
- What will be the size of the India pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the India pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in India's pharmaceuticals market?
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
8 Company Profiles
8.1. Lupin Ltd
8.2. Sun Pharmaceutical Industries Inc
8.3. Aurobindo Pharma Ltd
8.4. Dr. Reddy's Laboratories Limited
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
List of Tables
Table 1: India pharmaceuticals market value: $ billion, 2015-19
Table 2: India pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: India pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: India pharmaceuticals market share: % share, by value, 2019
Table 5: Lupin Ltd: key facts
Table 6: Lupin Ltd: Annual Financial Ratios
Table 7: Lupin Ltd: Key Employees
Table 8: Lupin Ltd: Key Employees Continued
Table 9: Sun Pharmaceutical Industries Inc: key facts
Table 10: Sun Pharmaceutical Industries Inc: Key Employees
Table 11: Aurobindo Pharma Ltd: key facts
Table 12: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 13: Aurobindo Pharma Ltd: Key Employees
Table 14: Dr. Reddy's Laboratories Limited: key facts
Table 15: Dr. Reddy's Laboratories Limited: Annual Financial Ratios
Table 16: Dr. Reddy's Laboratories Limited: Key Employees
Table 17: Dr. Reddy's Laboratories Limited: Key Employees Continued
Table 18: India size of population (million), 2015-19
Table 19: India gdp (constant 2005 prices, $ billion), 2015-19
Table 20: India gdp (current prices, $ billion), 2015-19
Table 21: India inflation, 2015-19
Table 22: India consumer price index (absolute), 2015-19
Table 23: India exchange rate, 2015-19
List of Figures
List of Figures
Figure 1: India pharmaceuticals market value: $ billion, 2015-19
Figure 2: India pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: India pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in India, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in India, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in India, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in India, 2019
Figure 10: India pharmaceuticals market share: % share, by value, 2019
Lupin Ltd
Sun Pharmaceutical Industries Inc
Aurobindo Pharma Ltd
Dr. Reddy's Laboratories Limited
*If Applicable.